Table 4.

Outcomes of all patients (who did and did not receive HL) presenting with gastrointestinal symptoms to the ED

	Admission to hospital			Return to the ED within 30 d			Outpatient follow-up
	OR	95% CI	P	OR	95% CI	P	OR	95% CI	P
Received only HL in the ED	0.25	0.14–0.470	0.000	0.88	0.58–1.36	0.566	0.64	0.37–1.13	0.119
Age	1.03	1.02–1.05	0.000	1.00	0.99–1.02	0.897	1.03	1.02–1.05	0.000
Sex (female)	0.96	0.67–1.38	0.807	0.77	0.56–1.070	0.121	1.67	1.1–2.55	0.017
Diabetes	2.13	1.38–3.3	0.001	1.54	1.01–2.340	0.046	1.09	0.68–1.76	0.732
BMI	0.99	0.97–1.02	0.581	1.00	0.99–1.03	0.781	1.02	1–1.05	0.204
Chronic opioid user	1.31	0.87–1.97	0.198	0.89	0.61–1.31	0.548	1.89	1.23–2.91	0.004
Cannabinoid user	1.65	1.110–2.47	0.013	1.29	0.910–1.83	0.154	0.73	0.48–1.12	0.145
Cyclic vomiting syndrome	1.41	0.71–2.85	0.332	1.28	0.71–2.33	0.422	1.15	0.500–2.630	0.747
Cannabinoid hyperemesis syndrome	1.72	1.04–2.860	0.037	0.90	0.57–1.45	0.673	0.66	0.33–1.34	0.249
Gastroparesis	2.75	1.79–4.24	0.000	1.49	0.990–2.26	0.056	1.60	1–2.57	0.051
Gastroesophageal reflux disease	1.20	0.65–2.21	0.566	1.23	0.71–2.120	0.469	3.17	1.8–5.61	0.000

Multiple binary logistic regression models including all variables above were used to predict OR for categorical outcomes. P is considered statistically significant at <0.05 (bold).

BMI, body mass index; CI, confidence interval; ED, emergency department; HL, haloperidol; OR odds ratio.